BioMarin (BMRN) PT Lifted to $87 at Jefferies Posts Q3

October 24, 2014 8:24 AM

Jefferies analyst Eun Yang reiterated a Buy rating and boosted his price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found